Brief: Viracta Therapeutics Secures $50 Mln Credit Facility From Silicon Valley Bank And Oxford Finance
Nov 5 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS SECURES $50 MILLION CREDIT FACILITY
FROM
SILICON VALLEY BANK AND OXFORD FINANCE
* VIRACTA THERAPEUTICS INC - CO AND SVB TO TERMINATE CO'S
PRIOR
$15.0 MILLION LOAN AND SECURITY AGREEMENT AND EXISTING $5.0
MILLION DEBT BALANCE WAS REFINANCED
* VIRACTA THERAPEUTICS INC - UNDER NEW CREDIT FACILITY,
REMAINING
$45.0 MILLION IS AVAILABLE IN TWO ADDITIONAL TRANCHES OF $20.0
MILLION AND $25.0 MILLION
Source text for Eikon: ID:nPn2wqVJDa
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update